← Leaderboards
Gregory M. Sokol
Indiana University Indianapolis
$1,737,345
Attributed
$1,737,345
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $468.9K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,737,345 · 3
By mechanism
UG1$1,139,080 · 2
U10$598,265 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Roland W. Herzog$25,146,618
- Jennifer Lynn Carnahan$902,450
- Christina Marie Scifres$1,622,925
- Mark Sebastian Sulkowski$12,713,668
- David W. Clapp$30,065,006
Others in their field
Top investigators on “High Risk”
- Lawrence Corey · Fred Hutchinson Cancer Center$561,333,990
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$424,554,257
- Wafaa M. El-Sadr · Columbia University Health Sciences$337,188,987
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$303,724,352
Research focus
High RiskIndianaGenomicsEnrollmentFollow-UpHospitalsConduct Clinical TrialsCritical IllnessDesignCollaborationsBasic ScienceFacultyCaringAdmission ActivityChildAcademic Medical CentersChildhoodClinical And Translational Science AwardsBirthClinical ServicesAreaClinical TrialsClinical ResearchInfant
Grant awards (8)
Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS)$211,851
UG1 · FY2025 · HD · contact PI
Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS)$218,269
UG1 · FY2024 · HD · contact PI
Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS)$224,498
UG1 · FY2023 · HD · contact PI
Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS)$468,862
UG1 · FY2021 · HD · contact PI
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network$7,800
UG1 · FY2017 · HD · contact PI
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network$7,800
UG1 · FY2016 · HD · contact PI
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network$303,380
U10 · FY2015 · HD · contact PI
Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network$294,885
U10 · FY2014 · HD · contact PI